Brand-Name Pricing (2026) Mounjaro (Diabetes Indication): List price: $1,069/month ($12,828/year) Without insurance: Pay full price With insurance: $25-$300/month copay (if covered) Availability: On shortage list periodically Zepbound (Weight Loss Indication): List price: $1,069/month ($12,828/year) Without insurance: Pay full price With insurance: $25-$300/month copay (if covered) Availability: Limited, shortage issues Manufacturer Savings Cards: Eli Lilly offers savings card Reduces cost to $25-$50/month Requirements: Commercial insurance (not Medicare/Medicaid) Exclusions: Cash-pay patients ineligible Income limits: May apply For uninsured or underinsured patients, brand-name is unaffordable at $1,069/month

Besides semaglutide, examples of other GLP-1 agonists include: Dulaglutide ( Trulicity ) Lixisenatide (Adlyxin) Tirzepatide ( Mounjaro , Zepbound ), a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist Saxenda Important Safety Information: Read more about serious warnings and safety info
And if we do that well, the first step they takewhether its a walk around the block or a short runhas a much better chance of turning into something long term
This colloquial term describes a common pattern of fat distribution that affects both men and women, though the underlying mechanisms differ between sexes
government funding for its bird flu vaccine trial